港股药明系午后跳水，药明康德跌超5%_老虎社区_美港股上老虎

港股药明系午后跳水，药明康德跌超5%

老虎资讯综合06-18

6月18日，港股药明系午后跳水，药明康德跌超5%，药明生物跌超4%，药明合联跌超2%。午间消息：美国《生物安全法案》风波下，中国CXO企业药明生物美国伍斯特基地暂停建设消息引发市场猜测。对于美国伍斯特基地进展情况，药明生物方面回复记者称，这是公司内部的正常调整，只是暂停。药明生物方面并没有回应是否跟美国《生物安全法案》草案风波有关，只是称：“所有基地在建设过程中，都会有设计调整，这是正常运营。”

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

在18楼看风景
·06-18
Nice
回复
点赞
举报
收起
- 在18楼看风景:
  $IS INDIA CLIMATE US$(I98.SI)$
  06-25
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1109327551?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","is_english":false,"pubTime":"2024-06-18 13:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109327551","market":"hk","top_or_hot":-1,"title":"港股药明系午后跳水，药明康德跌超5%","media":"老虎资讯综合","content":"<html><head></head><body><p>6月18日，港股药明系午后跳水，<a href=\"https://laohu8.com/S/02359\">药明康德</a>跌超5%，<a href=\"https://laohu8.com/S/02269\">药明生物</a>跌超4%，<a href=\"https://laohu8.com/S/02268\">药明合联</a>跌超2%。午间消息：美国《生物安全法案》风波下，中国CXO企业药明生物美国伍斯特基地暂停建设消息引发市场猜测。对于美国伍斯特基地进展情况，药明生物方面回复记者称，这是公司内部的正常调整，只是暂停。药明生物方面并没有回应是否跟美国《生物安全法案》草案风波有关，只是称：“所有基地在建设过程中，都会有设计调整，这是正常运营。”</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4ee7545351caddf2f1f54f537dafe2bb\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b0d44a0e66dd0b4324662c3e3931851b\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5dcff139a84b594ab7e334ebf57c451f\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股药明系午后跳水，药明康德跌超5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股药明系午后跳水，药明康德跌超5%\n</h2>\n\n<h4 class=\"meta\">\n\n2024-06-18 13:10 北京时间&nbsp;&nbsp;&nbsp;<strong>老虎资讯综合</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>6月18日，港股药明系午后跳水，药明康德跌超5%，药明生物跌超4%，药明合联跌超2%。午间消息：美国《生物安全法案》风波下，中国CXO企业药明生物美国伍斯特基地暂停建设消息引发市场猜测。对于美国伍斯特基地进展情况，药明生物方面回复记者称，这是公司内部的正常调整，只是暂停。药明生物方面并没有回应是否跟美国《生物安全法案》草案风波有关，只是称：“所有基地在建设过程中，都会有设计调整，这是正常运营。”</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0708995583.HKD","symbol_name":"TEMPLETON CHINA \"A\" (HKD) ACC","start_time":0,"source_url":"","article_id":"1109327551","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109327551","pubTimestamp":1718687434,"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"6月18日，港股药明系午后跳水，$药明康德(02359)$跌超5%，$药明生物(02269)$跌超4%，$药明合联(02268)$跌超2%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603259":"药明康德","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","HSCEI":"国企指数","LU1997245177.USD":"安联神洲A股基金","BK0216":"研究试验","HSTECH":"恒生科技指数","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","07226":"XL二南方恒科","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","02359":"药明康德","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU0052750758.USD":"富兰克林中国基金A Acc","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","BK1583":"高瓴概念","LU1046422090.SGD":"Fidelity Pacific A-SGD","YANG":"三倍做空富时中国ETF-Direxion"},"translate_title":"Hong Kong stock WuXi dived in the afternoon, WuXi AppTec fell more than 5%","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/e8e70dcfe2a8b661b3faedf31edaf8ee","symbols_score_info":{"603259":1,"07226":1,"YANG":1,"HSTECH":1,"HSCEI":1,"02359":1},"content_text":"6月18日，港股药明系午后跳水，药明康德跌超5%，药明生物跌超4%，药明合联跌超2%。午间消息：美国《生物安全法案》风波下，中国CXO企业药明生物美国伍斯特基地暂停建设消息引发市场猜测。对于美国伍斯特基地进展情况，药明生物方面回复记者称，这是公司内部的正常调整，只是暂停。药明生物方面并没有回应是否跟美国《生物安全法案》草案风波有关，只是称：“所有基地在建设过程中，都会有设计调整，这是正常运营。”","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":318089877291176,"gmtCreate":1718697203595,"gmtModify":1718697204990,"author":{"id":"3539141933667343","authorId":"3539141933667343","name":"在18楼看风景","avatar":"https://static.tigerbbs.com/c447c98b6b66b23b25324bc8f957da89","vip":1,"hat":"https://static.tigerbbs.com/5c5b6ed6e3b5dcb14f9ef3ceb365e412","crmLevel":1,"crmLevelSwitch":0,"idStr":"3539141933667343","authorIdStr":"3539141933667343"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/318089877291176","repostId":1109327551,"repostType":2,"repost":{"id":"1109327551","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1718687434,"share":"https://www.laohu8.com/m/news/1109327551?lang=&edition=full","pubTime":"2024-06-18 13:10","market":"hk","language":"zh","title":"港股药明系午后跳水，药明康德跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109327551","media":"老虎资讯综合","summary":"6月18日，港股药明系午后跳水，$药明康德(02359)$跌超5%，$药明生物(02269)$跌超4%，$药明合联(02268)$跌超2%","content":"<html><head></head><body><p>6月18日，港股药明系午后跳水，<a href=\"https://laohu8.com/S/02359\">药明康德</a>跌超5%，<a href=\"https://laohu8.com/S/02269\">药明生物</a>跌超4%，<a href=\"https://laohu8.com/S/02268\">药明合联</a>跌超2%。午间消息：美国《生物安全法案》风波下，中国CXO企业药明生物美国伍斯特基地暂停建设消息引发市场猜测。对于美国伍斯特基地进展情况，药明生物方面回复记者称，这是公司内部的正常调整，只是暂停。药明生物方面并没有回应是否跟美国《生物安全法案》草案风波有关，只是称：“所有基地在建设过程中，都会有设计调整，这是正常运营。”</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4ee7545351caddf2f1f54f537dafe2bb\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b0d44a0e66dd0b4324662c3e3931851b\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5dcff139a84b594ab7e334ebf57c451f\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股药明系午后跳水，药明康德跌超5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股药明系午后跳水，药明康德跌超5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2024-06-18 13:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>6月18日，港股药明系午后跳水，<a href=\"https://laohu8.com/S/02359\">药明康德</a>跌超5%，<a href=\"https://laohu8.com/S/02269\">药明生物</a>跌超4%，<a href=\"https://laohu8.com/S/02268\">药明合联</a>跌超2%。午间消息：美国《生物安全法案》风波下，中国CXO企业药明生物美国伍斯特基地暂停建设消息引发市场猜测。对于美国伍斯特基地进展情况，药明生物方面回复记者称，这是公司内部的正常调整，只是暂停。药明生物方面并没有回应是否跟美国《生物安全法案》草案风波有关，只是称：“所有基地在建设过程中，都会有设计调整，这是正常运营。”</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4ee7545351caddf2f1f54f537dafe2bb\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b0d44a0e66dd0b4324662c3e3931851b\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5dcff139a84b594ab7e334ebf57c451f\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","relate_stocks":{"603259":"药明康德","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","HSCEI":"国企指数","LU1997245177.USD":"安联神洲A股基金","BK0216":"研究试验","HSTECH":"恒生科技指数","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","07226":"XL二南方恒科","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","02359":"药明康德","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU0052750758.USD":"富兰克林中国基金A Acc","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","BK1583":"高瓴概念","LU1046422090.SGD":"Fidelity Pacific A-SGD","YANG":"三倍做空富时中国ETF-Direxion"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109327551","content_text":"6月18日，港股药明系午后跳水，药明康德跌超5%，药明生物跌超4%，药明合联跌超2%。午间消息：美国《生物安全法案》风波下，中国CXO企业药明生物美国伍斯特基地暂停建设消息引发市场猜测。对于美国伍斯特基地进展情况，药明生物方面回复记者称，这是公司内部的正常调整，只是暂停。药明生物方面并没有回应是否跟美国《生物安全法案》草案风波有关，只是称：“所有基地在建设过程中，都会有设计调整，这是正常运营。”","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":320643619098712,"gmtCreate":1719305194010,"gmtModify":1719305199253,"authorId":3539141933667343,"author":{"id":3539141933667343,"idStr":"3539141933667343","authorId":3539141933667343,"name":"在18楼看风景","avatar":"https://static.tigerbbs.com/c447c98b6b66b23b25324bc8f957da89","vip":1,"currentWearingBadge":{"badgeId":"a97bce155cb14045be40c3fe246e8d20-1","templateUuid":"a97bce155cb14045be40c3fe246e8d20","name":"新晋创作者","description":"首次获得精华帖的创作者","bigImgUrl":"https://static.tigerbbs.com/4ce9180a952c61a51c39f70d533b81a7","smallImgUrl":"https://static.tigerbbs.com/f98cf16cf4b858114f7ab9a779f9e6f1","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.07","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2005},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":318089877291176,"type":1,"supId":0,"prevId":0,"content":"<a href=\"https://laohu8.com/S/I98.SI\"> $IS INDIA CLIMATE US$(I98.SI)$ </a>","text":"<a href=\"https://laohu8.com/S/I98.SI\"> $IS INDIA CLIMATE US$(I98.SI)$ </a>","html":"<a href=\"https://laohu8.com/S/I98.SI\"> $IS INDIA CLIMATE US$(I98.SI)$ </a>"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":2,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}